Research graph
References from The Association between Symptoms and Microbiologically Defined Response to Tuberculosis Treatment. Local targets link to admitted publications; unresolved targets remain external evidence.
Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications
1999 · External reference
Unresolved reference
External reference
Surrogate markers and microbiologic end points
10.1086/653061 · 2010 · External reference
Correlation between bacteriologic and clinical endpoints in trials of acute otitis media
10.1097/01.inf.0000092637.66762.c6 · 2003 · External reference
A study of the impact of tuberculosis on the quality of life and the effect after treatment with dots
10.1177/1010539509336242 · 2009 · External reference
Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection
10.1378/chest.07-1494 · 2008 · External reference
Measuring health-related quality of life in tuberculosis: a systematic review
10.1186/1477-7525-7-14 · 2009 · External reference
Quality of life in tuberculosis: a review of the English language literature
10.1007/s11136-004-0374-1 · 2004 · External reference
Personal and societal health quality lost to tuberculosis
10.1371/journal.pone.0005080 · 2009 · External reference
Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis
10.1378/chest.07-0755 · 2007 · External reference
Once-weekly rifapentine and isoniazid versus twice-weekly rifampin and isoniazid in the continuation phase of therapy for drug-susceptible pulmonary tuberculosis: a prospective, randomized clinical trial among HIV-negative persons
10.1016/s0140-6736(02)09742-8 · 2002 · External reference
Relapse with rifamycin monoresistant tuberculosis in HIV-infected patients treated with supervised once-weekly rifapentine and isoniazid
10.1016/s0140-6736(98)11467-8 · 1999 · External reference
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
10.1164/rccm.200603-360oc · 2006 · External reference
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis
10.1164/rccm.200901-0078oc · 2009 · External reference
Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis
10.1164/rccm.200503-417oc · 2006 · External reference
Recurrent tuberculosis in the united states and canada: Relapse or reinfection?
10.1164/rccm.200408-1081oc · 2004 · External reference
Unresolved reference
1994 · External reference
R: A language and environment for statistical computing. 2.10.1 ed
2009 · External reference
Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months
10.1164/ajrccm/147.4.1062 · 1993 · External reference
Clinical symptoms and microbiological outcomes in tuberculosis treatment trials
10.1016/j.tube.2011.05.007 · 2011 · External reference
Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug Administration
10.1093/clind/15.supplement_1.s282 · 1992 · External reference
